Puma Biotechnology, Inc. is a company in the U.S. stock market and it is a holding in 32 U.S.-traded ETFs. PBYI has around 5.0M shares in the U.S. ETF market. The largest ETF holder of PBYI is the SPDR S&P Biotech ETF (XBI), with approximately 2.72M shares. Investors may also find of interest that the ETF with the largest allocation to PBYI stock is SPDR S&P Biotech ETF (XBI), with a portfolio weight of 0.53%. On average, U.S. ETFs allocate 0.07% of PBYI to their portfolios.
Additionally, PBYI is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PBYI as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 39.80%.